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doi:10.1016/j.ejvs.2008.12.005Abstract Introduction: This study aims to assess the patency, the clinical success and the
limb-salvage rates of combined subintimal (SA) coupled to endoluminal angioplasty (EA) as
the initial treatment of ischaemic inferior-limb ulcers in diabetic patients and to study the
influence of other concurrent factors in the tissue-healing process.
Materials and method: Since September 2002 until December 2007, a consecutive series of
176 limbs with manifold ischaemic wounds in 161 diabetic patients were treated by associ-
ated multilevel angioplasties in a multidisciplinary ‘diabetic-foot team’ (a third-line dia-
betic-care institution integrating two departmental hospitals). There were 98 associated SA
with EA procedures, 26 re-vascularisations by single SA technique and 52 others including
selective multilevel EAs that were retrospectively reviewed. The mean follow-up period
was 22.1 months (in the range of 1e50 months) by clinical and duplex evaluation (every 6
months).of Vascular Surgery, Princess Paola Hospital, Rue du Vivier, 21, 6900 Marche-en-Famenne, Belgium.
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Angioplasty for Diabetic Ischaemic Wounds 449Results: The initial technical success was noted in 149 limbs (84%). For the single or associ-
ated SA procedures, 102 of 124 procedures were successful (82%) and 145 of 150 of the
miscellaneous EAs (96%) evinced an equally favourable outcome. The 27 initially failed endo-
vascular procedures (22 SA and five EA) required 16 surgical re-vascularisation, eight adjuvant
endovascular procedures besides three amputations. A total of 21 secondary and five tertiary
angioplasties were equally necessary during the entire follow-up period of these patients.
The 30-day survival rate was 99% (one patient died from myocardial infarction). In a inten-
tion-to-treat analysis, the cumulative primary and secondary patencies at 12, 24, 36 and
48 months were 62%, 45%, 41% and 38%, together with 80%, 69%, 66% and 66%, respectively.
The aggregate clinical success rates at the same intervals were 86%, 77%, 70% and 69%, while
the corresponding limb-salvage proportions showed 89%, 83%, 80% and 80%, respectively. The
primary patency was negatively affected at 1 and 4 years by the length of the occluded
segment (>10 cm) and the end-stage renal disease (ESRD) (p< 0.0001). The limb-salvage
rates were unfavourably influenced at the same periods by the extent of tissue defects
(>3 cm), the ESRD and the presence of osteomyelitis. In addition, at 4 years, the age (>70
years), the accompanying peripheral neuropathy, the bedridden status and the presence of
cardiac failure (left ventricular ejection fraction (LVEF)< 30%) appeared equally as negative
predictors (p< 0.0001) for wound healing and limb rescue.
Conclusion: Primary angioplasty represents a low aggressive and efficacious method to
improve the healing process in diabetic ischaemic ulcers. However, beyond appropriate
re-vascularisation, even repetitive if necessary, achieving satisfactory limb-salvage rates
probably implies a multidisciplinary control of the presenting risk factors for wound healing
as well.
ª 2008 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.Primary angioplasty in the treatment of chronic inferior
limb (TASC A and B lesions), has been showed to compare
with both prosthetic and venous bypass surgery.1 With
regards to the critical-limb ischaemia (CLI) and the more
severe TASC C and D arterial lesions,1 observational2e4 or
recent randomised studies5 indicate equivalent short- to
medium-term results for the two therapeutic options.
For this category of frail (fragile) patients world over,
the features of the disease/morbidity e involving extended
inflammation and tissue loss e make them somewhat
reluctant to undergo re-vascularisation.6,7 However,
increasing contemporary reports are to date proposing
primary angioplasty as feasible procedure in most diabetic
subjects with optimal clinical results.1,4,8,9
The purpose of this study was twofold: first, to assess
the technical and clinical outcome of combined subintimal
(SA) and endoluminal angioplasty (EA) as the primary
therapeutic strategy in diabetic patients with CLI ulcers in
a non-academic (tertiary referral) diabetic centre. Second,
we tried to consider and rank, in a multidisciplinary
approach, the influence of several concurrent factors
participating in the healing process of diabetic wounds,
beyond the angioplasty-related re-establishment of flow.
Material and methods
Patients
Since September 2002 until December 2007, a series of 176
inferior-limb ischaemic wounds in 161 diabetic CLI patients
were treated in our institution (two departmental hospitals)
by primarymultilevel angioplasties andwere retrospectively
analysed following convenient ethical approval. Fifteen
patients received a staged, bilateral re-vascularisation. Allpatients were intended for a primary angioplasty approach,
excepting the cases with extensive or irrecoverable foot
gangrene (Wagner stage 5)10 and inevitable amputation.
There were 98 associations of SA with EA procedures, 26 re-
vascularisations by single SA technique and 52 others
involving selective multilevel EAs. Severe ischaemic ulcer-
ations, distal necrosis and swelling (Rutherford categories 5
and 6)11 were appointed either at the foot level (Wagner
classification grade 2e4)10 in 104 limbs (59%) or as isolated
calf ulcers in 42 cases (24%). In 30 (17%) limbs, complex
below-the-knee trophic lesions were noted. This series
included 98 men, and the mean age was 70.9 years (in the
range of 46e89 years). Patient characteristics and risk
factors are summarised in Table 1. Of the diabetic pop-
ulation included in this study, 33% of the cases (59 of 176)
were insulin dependent and 70% (124 of 176) presented
different stages of peripheral neuropathy according to the
UK screening test scale.12 Over two-thirds of the patients
exhibited more than 10 years of assigned diabetes.
Single SA (nZ 26) or associated with EA (nZ 98) was
realised in an extra-luminal manner in a total of 124 limbs
(70%). The presence of aneurismal disease, recent occlu-
sions with echo-lucent material (systematic preoperative
duplex evaluation) or clinical acute ischaemia was not
considered for this approach. The mean length of the re-
canalised segments was 8.6 cm (ranging from 3 to 28 cm). In
five cases, SA was realised in limbs with previous femoro-
popliteal (nZ 4) or femoro-distal (nZ 1) failed bypasses.
EA, as the sole technique (nZ 52) or associated with
SA (nZ 98), was performed in a total of 150 cases of
stenoses> 70% and also for short occlusions (<3 cm). In
practice, a path of least resistance (endo- or extra-luminal)
was attempted to re-canalise all the long and short occlu-
sions (nZ 134, by using SAZ 124 and EAZ 10), while pure
stenoses (nZ 42) were treated via a luminal approach. The
Table 1 Patients’ features and risk factors
Patients characteristics/risk factors Nr. limbs
(nZ 176)
(n%)
Age> 70 years nZ 73 41
Hypertension nZ 123 69
Smoking nZ 90 51
Coronary disease nZ 122 69
Ejection fraction< 35% nZ 42 23
Chronic renal insufficiency nZ 86 48
End-stage renal disease dialysis nZ 33 18
Hypercholesterolemia nZ 101 57
Cerebrovascular disease nZ 40 22
COPD nZ 49 27
Local features/limbs
Two or three crural artery occluded nZ 129 73
Incomplete or occluded pedad
pedal arch
nZ 36 20
Length of the occlusion 10 cm nZ 55 31
Peripheral neuropath/the UK
screening scoreb: (1e9 pts)
nZ 124 70
Osteitis nZ 57 32
Wagner scorea grades 2e5 nZ 79 44
Bedridden nZ 20 11
a Wagner classification.
b UK Neuropathy screening centre.
450 V. Alexandrescu et al.technical features of the 98 combined EA and SA inter-
ventions are presented in Table 2. The complementary
details concerning the independent SAs or EAs are displayed
in Table 3.
Focussing on the segment that presented the main
lesions, we graded the limbs as follows: 14 limbs (8%) with
TASC type B lesions, 70 cases (40%) featuring TASC type C
arterial disease (iliac, nZ 1; femoro-popliteal, nZ 17 andTable 2 The technical characteristics of the 98 combined endo
Leading SA The main procedure
(nZ 98)
Acc
Initiation level Re-entry level Iliac
ILIAC (nZ 5) Common iliac (nZ 1)
External iliac (nZ 3)
Common femoral (nZ 1)
Femoro-popliteal (nZ 34) SFA (nZ 5) 1
Proximal popliteal (nZ 12) 3
Distal popliteal (nZ 3) 1
Tibio-peroneal trunk (nZ 4)
Peroneal (nZ 7) 1
Post. tibial (nZ 3)
Infra-popliteal
and crural
(nZ 59) Ant. tibial (nZ 7)
Pedal artery (nZ 2)
Post. tibial (nZ 23) 2
Plantar artery (nZ 8)
Peroneal (nZ 19)crural, nZ 52) and 92 limbs (52%) revealing TASC type D
lesions (iliac, nZ 1; femoro-popliteal, nZ 22 and crural,
nZ 69).1 According to the number of patent tibial arteries
persisting in the calf (scored from 0 to 3), the mean crural
arterial run-off was 0.8 at the time of the procedures.
Definitions
Tabulation of the clinical information of the inferior-limb
ischaemia was evaluated according to the revised criteria
of SVS/ISCVS10 and the TASC (II) recommendations.1 The
sensory neuropathy has been quantified using the Semmese
Weinstein monofilaments according to the UK peripheral
neuropathy screening score12 and the Wagner classification
was employed to itemise the foot trophic lesions.10
Patency, limb-salvage and survival rates were defined
based on the recommended standard of reporting prac-
tices.11 Technical success was noted in the absence of
residual stenosis in >20%. Clinical success was recorded
when there was an increase in the ankleebrachial index
(ABI) of >0.10 or marked healing trends (improvement with
at least two Rutherford categories with or without minor
amputations).
Statistical analysis
All the results were reported in an intention-to-treat
analysis. The KaplaneMeier life-table method was used to
determine the outcome of the primary and secondary
patencies, the clinical success, the limb-salvage and the
patient-survival rates at sequential time intervals. The
initial technical success and primary patency results of our
team were compared between the first- and the second-
half time period of our experience (years: 2002e2004 vs.
2005e2007) using the log-rank (ManteleCox) and the Bre-
sloweWilcoxon tests. Specific parameters were analysed as
categorical variables at 1 and 4 years, applying the two-luminal and subintimal angioplasties
ompanying EAs
Profonda
fem
SFA Popliteal Anterior
tibial (AT)
Posterior
tibial (PT)
Peroneal
1
1 2
1
1 2 1
1 2 5 1
1 1
3 1
1 5
1 2
3 1 2 1
1 1
14 1 3 3
2 5 1
5 3 3 7
Table 3 Specificities of the interventions requiring a single type of angioplasty
Independent
SAs (nZ 26)
Independent
EAs
(nZ 52)
Initiation level Re-entry level Target Lesion Iliac Profonda
fem
SFA Popliteal Anterior
tibial (AT)
Posterior
tibial (PT)
Peroneal
Iliac (nZ 3) Common iliac (nZ 1) nZ 52 nZ 7 nZ 1 nZ 8 nZ 3 nZ 12 nZ 16 nZ 5
External iliac (nZ 1) Associated
EAs performed
in the same
setting:
Common
femoral
(nZ 1) ILIAC 1
Femoro-popliteal
(nZ 7)
Distal popliteal (nZ 3) CONTRLAT./ILIAC 1 1 1 1 1
Tibio-peroneal
trunk
(nZ 3) COMMON FEM 1
Peroneal (nZ 1) SFA 1 3 5 2
Post. tibial (nZ 1) CONTRALAT./SFA 1
Infra-popliteal
and crural
(nZ 16)
Post. tibial (nZ 5) POPLITEAL 1 1 1 3 1
Ant. tibial (nZ 3) PROFONDA FEM 1 1 1
Plantar artery (nZ 1) Ant. tibial 1
Pedal artery (nZ 1) Post. tibial 1 1 1 1
Peroneal (nZ 3) Tibio-peroneal
mark
1 3 1
Peroneal distal (nZ 3) Peroneal 1 1 2 2
Plantar arteries 1 1 2
Pedal 1 1
Angioplasty for Diabetic Ischaemic Wounds 451sided Fisher’s exact test. A p-value of <0.05 was considered
statistically significant. All data were incorporated in the
‘GraphPad In Stat’ statistics software (Graph Pad Software,
Inc., San Diego, CA, USA).
The SA and PTA techniques
The preoperative medication of 160 mg of aspirin daily or
clopidogrel 75 mg per day started at least 72 h before the
procedure was included in each case. The SA procedures
(Fig. 1) were carried out using a previously standardised
protocol.13 All the patients received 5000 IU of heparin
before crossing the lesion. In some difficult re-entry
manipulations (mostly due to local calcifications), an angled
5-F ‘vertebral’ catheter (Cook, UK) or a 5-F ‘PIER’ catheter
(Cordis, USA) was used with good results. Occasionally, the
support of an ‘out-back’ catheter (LuMend, Inc., Redwood
City, CA, USA) ensured satisfactory results in four laborious
re-canalisations. It is the author’s practice to inject small
doses of contrast through the 5-F catheter periodically
during the dissection, in order to assess the eventual
uncertain recovery of the true lumen and the state of
collaterals. Nitinol stents were placed above the knee
(nZ 44, 25%) only selectively after suboptimal EA (residual
stenosis> 20%) or only if elastic recoil in the SA channel was
evidenced. For the below-the-knee EAs, usually a 2.5e3-mm
low-profile balloon in a monorail 0.014-inch system (Savy,
Cordis Corp., USA) or in a more stiff 0.018 over the wire
system (ReeKross, Clear Stream Technologies Ltd.) was
employed, strengthened by a 50e60-cm 6-F introducer
sheath (Cordis, USA or Cook, UK). In 14 cases, cuttingballoons (Boston, Inc., USA) were needed to treat annular
calcifications in the popliteal or calf vessels (nZ 12) or for
the presence of myointimal hyperplasia after previous
stenting of the superficial femoral artery (SFA; nZ 2).
All patients were prescribed aspirin (160 mg per day)
after the procedure, unless intolerant or previous treat-
ment with clopidogrel, ticlopidin or oral anticoagulation. In
such cases, these latest medications were prolonged.
Other local wound treatment included debridement,
disinfection and, in selected cases, linear closure or skin
grafts (autografts) were applied. In this group of study, no
other auxiliary methods to stress local tissue regeneration
(vacuum-assisted wound closure, biosynthetic skin substi-
tutes or hyperbaric oxygen therapy) were added after the
first targeted re-vascularisation.
Follow-up
The patients were postoperatively followed up with peri-
odical clinical and duplex scan evaluation, including the ABI
quantification when feasible. This follow-up was scheduled
1 month after discharge and every 6 months thereafter. The
mean follow-up was 22.3 months (in the range of 1e61
months).
Results
The aggregate initial technical success was noted in 149
limbs (84%). For the whole SA procedures, 102 of the 124
patients were successful (82%), and 145 of the 150 patients
Figure 1 (a) Severe critical-limb ischaemia (CLI) athero-
sclerotic pattern involving all the crural arteries. (b) Combined
SA and EA re-vascularisation with re-opening of the three tibial
trunks. (c) Initial presentation of the foot with tissue necrosis
of the right hallux (Wagner grade 3) and inflammatory swelling.
(d) Clinical result at 5 months.
452 V. Alexandrescu et al.undergoing miscellaneous EA interventions (96%) evinced
an equally favourable outcome.
In the 27 initially failed endovascular interventions (22 SA
and five EAs), majority were noted following SAs, due to the
lack of re-entry of the true lumen (nZ 14). Conversely,
a difficult initiation of the subintimal plane was assigned in
four SAs. The other four SA inadequacies included an arterial
wall perforation and a failure to seal a leak or to re-start
a new extra-luminal channel (nZ 1) and the occurrence of
elastic recoil with secondary thrombosis of the subintimal
channel (nZ 3). There were five EA failures with regards to
suboptimal dilatations (residual stenosis> 20%) in the
context of heavy crural-vessel calcifications.
Surgical re-vascularisations were mandatory in 16
instances (14 bypasses and two thrombectomies), other
adjuvant endovascular procedures were performed in eightlimbs (three iterative SAs, two percutaneous thrombo-
aspirations and three local thrombolysis along with EA),
besides three inevitable amputations.
The ABI assessment showed a mean increase of 0.34 (in
the range of 0.10e0.70). The aggregate 30-day peri-oper-
ative complication rate (in an intention-to-treat analysis)
was 12% (22 of the 176 cases). Major complications were
noted in 10 cases (5%): four limbs exhibiting initial acute
ischaemia and surgical re-vascularisation, one myocardial
infarction treated by emergent coronary angioplasty, three
reversible renal insufficiencies (contrast-enhanced) and
two groin haematomas claiming surgical haemostasis.
Minor complications with confined clinical rebounds
were registered in 12 other cases (7%): (1) three cases of
distal spasms cleared by nitroglycerin-derivatives adminis-
tration, (2) four cases of flow-restricted arterial perfora-
tions managed by prolonged balloon occlusion (nZ 2) and
stent placement in the SFA (nZ 2), (3) three cases of distal
embolisms controlled by percutaneous (nZ 1) or surgical (n
Z 2) thrombectomy and (4) two superficial groin haema-
tomas having spontaneous local resolution.
The 30-day survival rate was 99% (one case of myocardial
infarction). The cumulative primary and secondary
patencies at 12, 24, 36, 48 and 60 months (SEM) were 62%
(3.8), 45% (4), 41% (4.4), 38% (4.7) and 38% (5),
together with 80% (3.1), 69% (3.7), 66% (4.4), 66%
(4.3) and 66% (4.3), respectively, in a intention-to-treat
analysis.
The aggregate clinical success rates at the same inter-
vals were 86% (2.8), 77% (4.1), 70% (5.6), 69% (5.8)
and 69% (5.8), while the corresponding limb-salvage
proportions showed 89% (2.6), 83% (3.8), 80% (4.6),
80% (4.8) and 80% (4.8) in a same approach (Fig. 2).
The primary patency correlated to the initial technical
success and the limb-salvage data were compared between
the first- and the second-half time period of our experience
(September 2002eDecember 2004 vs. January 2005e
December 2007) using the log-rank (ManteleCox) and the
BresloweWilcoxon tests (Figs. 3 and 4). While primary
patency significantly improved during these two periods
following an inherent learning curve of our team (Fig. 3)
(pZ 0.039, confidence interval; CI: 1.030e3.365, HR: 1.86,
Chi squareZ 5.31), there was no statistical expression
concerning the limb-salvage rates (pZ 0.64, CI: 0.48e3.35,
HR: 1.27, Chi squareZ 0.23) (Fig. 4). The distribution of
complications and initial failures was also perhaps relevant
in the concept of learning curve: while three acute
ischaemias were noted in the first period instead of one in
the second, there were 16 technical failures in 77 patients
(20%) in the first interval vs. 11 failures in 99 patients (11%)
in the second time period.
Primary patency and limb salvage were also analysed
related to the presence/absence of some specific factors
using the univariable twofold Fisher’s exact test.
While the length (>10 cm) of the treated artery and
ESRD were negative predictors at 1 and 4 years
(p< 0.0001), the decline of the left ventricular function
(ejection fraction< 30%) appeared significant only at 4
years (p< 0.0001) for the primary patency. With regards to
the limb salvage, this was unfavourably affected at both
intervals by the extent of the tissue loss (ulcers> 3 cm),
the presence of osteomyelitis and the co-existence of ESRD
Figure 2 The cumulative primary, secondary patency, clinical success and limb-salvage rates using the KaplaneMeier life-table
method. All results were reported in an intention-to-treat analysis, including the 27 initial technical failures.
Angioplasty for Diabetic Ischaemic Wounds 453(p< 0.0001). The same parameter showed a detrimental
correlation with age (>70 years), poor ejection fraction
(<30%), peripheral neuropathy and the bedridden status of
patients (p< 0.0001) merely at 4 years.
A global stratification of the 176 treated ischaemic limbs
revealed a complete healing of ulcers with or without minor
amputation in 129 of the 176 limbs (73%) mainly in the 4th
to the 6th month following the initial intervention. In the
reminder 47 cases (including the three early amputations),
despite the recovery of a correct postoperative arterial
flow (duplex control), there were 40 limbs that never
became ulcer-free and four additional amputations for
extensive local sepsis in Wagner grade 3e4 lesions. Totally,Figure 3 A comparative appraisal of the technical success and the
vs. January 2005 and December 2007, using the log-rank (Mantelefor the 44 ulcerated limbs (25%), re-vascularisation ‘alone’
could not influence the local recovery process. On the other
hand, within the initially 129 unimpaired healed limbs, in
40 of the 129 limbs, recurrent ulcerations appeared after
a mean ‘wound-free’ period of 10.6 months (in the range of
3e26 months). Globally, during the entire follow-up period,
a total of 23 secondary, five tertiary angioplasties, 17
bypasses and five other secondary surgical procedures were
noted, mostly in the first 10 postoperative months.
Throughout the study period, there were 24 (13%) major
amputations (three in the early failures, four in the group
of correct angioplasty issues and 17 among the whole
follow-up, following iterative re-vascularisations or woundprimary patency between September 2002 and December 2004
Cox) and the BresloweWilcoxon tests.
Figure 4 Similar estimation concerning the limb-salvage rates between the two half time periods of our experience, applying
analogous statistical resolution.
454 V. Alexandrescu et al.relapses). We documented 67 (38%) minor amputations,
while 36 patients died (25 of cardiac and other vascular-
related causes, four of neoplasic disease, two of pulmonary
sepsis, four of miscellaneous renal and digestive aetiologies
and one of an unspecified cause). The cumulative survival
rates (Fig. 5) were 93%, 81%, 70%, 60% and 45% at 12, 24, 36,
48 and 60 months, respectively.
Discussion
Although most of the diabetic inferior-limb ulcers appear
neuropathic, in more than 40% of the cases, ischaemic
participation has also been evoked.1,10,14,15 Primary infra-
inguinal angioplasty for CLI became increasingly reported
as feasible, with low complications and comparable limb-
salvage proportions with surgery.1,4,5,8,16
The SA technique has emerged a few decades ago,13
gaining an increasing popularity in the treatment of longFigure 5 The survival rate of the patients during the study
follow-up.occluded arterial segments not only in claudicants but also
in CLI.4,9,17 A relatively high restenosis rate is probably
compensated by its low invasiveness, reduced cost and
hospital stay and a wide reproducibility, without interfering
with further surgical options.4,9,17 These points seem to be
in line with our observations. The mid-term primary
patency rates were modest, influenced by an incontestable
learning curve: 39% and 37% at 2 and 3 years in the first-half
of our experience and 53% and 46% at the same time
intervals after 2005 (Fig. 3).
Dick et al., in line with the observations of De Rubertis
et al., emphasise the reduced primary patency rates for
angioplasty, particularly in the subset of diabetic CLI pop-
ulation.8,18 They conclude, however, that the diabetic
context should not be considered a contraindication to
endovascular therapy, whose benefit may be mandatory to
a close surveillance and sustained iterative procedures. In
our practice, the primary angioplasty approach has become
a consistent policy to treat the complex lesions encoun-
tered in the diabetic CLI limbs. Whether it concerns
occlusions, targeting a substitutive endo- or extra-luminal
passage in a plane of decreased resistance, or for stenoses
through the native endoluminal way, an opening channel
through angioplasty has been attempted. However, the
relatively high percentage of initial technical failures (16%)
in our series may probably correlate with two independent
factors: (1) a wide inclusion criteria also including ‘hostile’
endovascular presentations (long diseased segments, failed
bypasses or extended calcifications) and (2) the principal
use of angioplasty in this series as the sole endovascular
technique, probably to be included in our future experi-
ence with other alternative methods in selected cases
(laser re-canalisations or rotational endarterectomy, etc.).
The endovascular patency seems to be independently
hampered by specific factors such as the length of the
diseased arterial segment17 and the addition of renal
insufficiency.1,4,19,20 These observations are joining our
notifications. In addition, the ESRDs have been found to be
Angioplasty for Diabetic Ischaemic Wounds 455favourable for limb salvage in our group (p< 0.0001 at 1
and 4 years) matching with other similar clinical
reports.6,19,20 Unlike primary patency, limb salvage was less
affected during the different periods of the study: 80%, 79%
before 2005 and 86%, 80% after this time period, respec-
tively (Fig. 4), owing probably to the propensity for early
and iterative re-vascularisations.
Other factors detrimental to limb salvage in our group
were the congestive heart failure and the impaired ambu-
lation, having equal connotations in the series of Conrad
et al. 21 and Taylor and colleagues.22
Owing to multidisciplinary team surveillance,
a complete healing of ulcers with or without minor ampu-
tation was assigned in 129 of the 176 limbs (73%), while nine
others showed consistent trends for recovery but without
complete closure. These data seem to fit with the results of
Bargellini et al. who observed 75% ulcer closures after
primary infra-inguinal SAs, during a mean follow-up of 23
months,20 or according to the 77% healing proportion at 1
year reported by the EURODIALE study.23 In our experience,
majority of the tissue defects were recovered between the
4th and 6th month, and these observations corroborate
with other similar analysis.15,21,23
Neuropathy was also a relatively common characteristic
in our group (63%) and was found to induce a pejorative
influence on limb salvage at 4 years (p< 0.0001).
Some authors have suggested that successful re-vascu-
larisation improves the arteriolar circulation in the foot
substantially, but not completely, yet the diabetic neuro-
pathic limbs still remain at risk for further ulcerations or
failure to heal.10,14,23
In the present study, the other factors resulting in
unfavourable outcome on limb salvage, with matching
analogous observations in the literature, were the ulcer
sizes and depth,10,15,23 older age23 and the presence of
local sepsis.14,15,23
The present study has some clear limitations. First, the
re-vascularisation technique reflects the experience of
three interventionists, therefore their inherent learning
curves, personal preferences in patient selection and
technical skills could have biased the uniformity of the
results. Second, the retrospective nature of the study has
resulted in the relatively fewer number of cases, thus
limiting a more refined statistical interpretation.
In our experience, by scoring the manifold pattern of the
diabetic CLI arterial lesions in occlusions and stenotic
segments, primary angioplasty plays a useful role in
attempting to restore a distal flow towards the ischaemic
tissue zones. Considering both the endo- and extra-luminal
paths as flexible therapeutic facets, our group recommends
this approach along with a multidisciplinary dialogue and
surveillance of concomitant determinants threatening limb
salvage.
Conclusion
Primary angioplasty represents a low-invasive and effica-
cious method to increase the local conditions for healing in
diabetic CLI wounds. Apart the re-establishment of the
haemodynamic conditions even appointed by iterative
interventions, parallel factors potentially threatening
tissue recovery and limb salvage need to be controlled bya meticulous follow-up and an aggressive multidisciplinary
therapeutic approach.Acknowledgements
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